In a significant development for Canadian fertility care, Pollin Fertility, a cutting-edge fertility clinic and technology firm, revealed a substantial $20 million Series A funding round.
The funding, spearheaded by Osmington, owned by David Thomson, marks one of the largest investments in a Canadian fertility company to date. The infusion positions Pollin as a major player in the reproductive healthcare arena.
Led by esteemed fertility physician Dr. Kim Garbedian, Pollin’s expansive 25,000 sq. foot clinic in Toronto is set to open its doors to patients on October 16, promising state-of-the-art facilities and groundbreaking advancements in fertility treatment.
Want to know more? Check out the source code on Newswire.ca.